HomeCompareBXPHF vs SBUX

BXPHF vs SBUX: Dividend Comparison 2026

BXPHF yields 5000.00% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BXPHF wins by $62217131802825.19M in total portfolio value
10 years
BXPHF
BXPHF
● Live price
5000.00%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62217131802825.35M
Annual income
$59,861,980,287,378,210,000.00
Full BXPHF calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — BXPHF vs SBUX

📍 BXPHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBXPHFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BXPHF + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BXPHF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BXPHF
Annual income on $10K today (after 15% tax)
$425,000.00/yr
After 10yr DRIP, annual income (after tax)
$50,882,683,244,271,480,000.00/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, BXPHF beats the other by $50,882,683,244,271,420,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BXPHF + SBUX for your $10,000?

BXPHF: 50%SBUX: 50%
100% SBUX50/50100% BXPHF
Portfolio after 10yr
$31108565901412.76M
Annual income
$29,930,990,143,689,142,000.00/yr
Blended yield
96.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

BXPHF
No analyst data
Price Target
$0.27
+575.0% upside vs current
Range: $0.27 — $0.27
Altman Z
-4.7
Piotroski
3/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BXPHF buys
0
SBUX buys
0
No recent congressional trades found for BXPHF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBXPHFSBUX
Forward yield5000.00%2.84%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$62217131802825.35M$167.0K
Annual income after 10y$59,861,980,287,378,210,000.00$71,136.45
Total dividends collected$62057786341622.61M$136.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst price target$0.27$104.00

Year-by-year: BXPHF vs SBUX ($10,000, DRIP)

YearBXPHF PortfolioBXPHF Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$510,700$500,000.00$11,121$420.68+$499.6KBXPHF
2$24,410,935$23,864,485.98$12,548$648.40+$24.40MBXPHF
3$1,092,192,501$1,066,072,800.30$14,440$1,013.98+$1092.18MBXPHF
4$45,746,366,951$44,577,720,975.17$17,068$1,617.30+$45746.35MBXPHF
5$1,793,932,828,410$1,744,984,215,772.56$20,912$2,649.52+$1793932.81MBXPHF
6$65,871,973,805,320$63,952,465,678,921.49$26,875$4,499.29+$65871973.78MBXPHF
7$2,265,146,887,602,700$2,194,663,875,631,007.20$36,771$8,014.12+$2265146887.57MBXPHF
8$72,954,689,148,998,180$70,530,981,979,263,280.00$54,542$15,197.11+$72954689148.94MBXPHF
9$2,201,076,182,660,884,700$2,123,014,665,271,456,500.00$89,602$31,242.49+$2201076182660.79MBXPHF
10$62,217,131,802,825,350,000$59,861,980,287,378,210,000.00$167,011$71,136.45+$62217131802825.19MBXPHF

BXPHF vs SBUX: Complete Analysis 2026

BXPHFStock

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase IIb clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in Leederville, Australia.

Full BXPHF Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this BXPHF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BXPHF vs SCHDBXPHF vs JEPIBXPHF vs OBXPHF vs KOBXPHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.